TALIS BIOMEDICAL CORP - COM NEW (TLIS) Institutional Ownership

CUSIP: 87424L207

13F Institutional Holders and Ownership History from Q2 2023 to Q1 2025

Type / Class
Equity / COM NEW
Symbol
TLIS
Price per share
$1.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 87424L207?
CUSIP 87424L207 identifies TLIS - TALIS BIOMEDICAL CORP - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of TALIS BIOMEDICAL CORP - COM NEW (TLIS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$26 $1.40 0
2024 Q4 14 $26 -$460,345 $1.86 1
2024 Q3 248,849 $460,371 -$6,052,498 $1.85 2
2024 Q2 789,494 $6,842,021 -$26,793 $8.66 18
2024 Q1 792,526 $6,934,526 -$20,723 $8.75 18
2023 Q4 796,612 $5,934,790 +$418,334 $7.45 18
2023 Q3 740,595 $4,272,687 -$39,727,415 $5.77 18
2023 Q2 7,634,835 $3,664,721 +$3,664,721 $0.48 2